Pay in 4 interest-free payments of $7.12 Learn more
Ships within 48 hours · Estimated delivery Aug 30 - Sep 4
For the anti-obesity medication (AOM) cohort, patients who had one or more pharmacy claims for Zepbound or Wegovy between 1 November 2023, and 31 December 2023, were identified (identification period)
Bjorkholm C, Monteggia LM
This may include reducing alcohol intake and avoiding certain medications unless prescribed
Tirzepatide is increasingly considered a long-term metabolic management tool rather than a short-term weight loss course
Providers also monitor liver enzymes and lipid panels to track metabolic improvements
Carnitine panel was abnormal in half of the patients in whom it was measured with 33% of the patients having high-esterified carnitine and 17% having low free carnitine
US$ 25.01
US$ 26.85
US$ 28.38
US$ 26.25
US$ 25.96
US$ 20.49
